(Q36790156)

16 August 2017

1 reference

title

Recent advances in therapy for gastrointestinal stromal tumors (English)

1 reference

16 August 2017

Robert G Maki

1

0 references

publication date

1 May 2007

1 reference

16 August 2017

published in

Current Oncology Reports

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

165-169

1 reference

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

16 August 2017

cites work

1 reference

12 December 2020

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 reference

12 December 2020

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

12 December 2020

Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

1 reference

12 December 2020

STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1.

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas

1 reference

12 December 2020

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

1 reference

12 December 2020

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

1 reference

12 December 2020

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

1 reference

12 December 2020

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

1 reference

12 December 2020

Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate

1 reference

12 December 2020

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

12 December 2020

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

12 December 2020

10.1007/S11912-007-0017-0

Identifiers

DOI

1 reference

16 August 2017

1 reference